ACHIEVE Africa – Innovation in, by, and for Africa

ACHIEVE Africa: Accelerating Health Innovation, Equity, and Development of Vaccines and Biologics in Africa

Africa stands at a pivotal moment in its journey toward health security and self-reliance. Scientific capacity is expanding and biomanufacturing is scaling up—yet global health financing is declining. This decline puts hard-won progress at risk and exposes fragile systems. This moment calls for African-led solutions more than ever.

ACHIEVE Africa is an African-led, African Union member-state-championed continental response to this moment. It is a US$100+ million initiative designed to close Africa’s research and development gap, and strengthen the continent’s engine for vaccines and biologics, from discovery through clinical trials and regulatory readiness.

Rooted in the African Union’s Agenda 2063 and aligned with the goal of producing 60% of Africa’s vaccines locally by 2040, ACHIEVE Africa builds the full value chain from discovery to delivery: designing, developing, testing, and manufacturing vaccines and biologics end to end, for health priorities defined by Africa.

ACHIEVE Africa extends an open invitation to partners in Africa and worldwide—governments, scientists, institutions, manufacturers, and global partners—to join in building Africa's end-to-end research and development ecosystem, delivering innovation developed in Africa, for Africa.

ACHIEVE Africa already involves scientists from 20 African countries and 50 institutions.

Governments, organizations, and philanthropies are welcome to contribute to scientific
strengthening, technology transfer, human resource development, matched funding, and collaboration.

ACHIEVE Africa is enabling a research and development ecosystem that supports the development, testing, and manufacturing of vaccines and biologics by, in, and for Africa.

ACHIEVE Africa: Accelerating Health Innovation, Equity, and Development of Vaccines and Biologics in Africa

ACHIEVE Africa extends an open invitation to partners in Africa and worldwide—governments, scientists, institutions, manufacturers, and global partners—to join in building Africa's end-to-end research and development ecosystem, delivering innovation developed in Africa, for Africa.

ACHIEVE Africa already involves scientists from 20 African countries and 50 institutions.

Governments, organizations, and philanthropies are welcome to contribute to scientific
strengthening, technology transfer, human resource development, matched funding, and collaboration.

ACHIEVE Africa was launched through a co-convening by:

ACHIEVE Africa is enabling a research and development ecosystem that supports the development, testing, and manufacturing of vaccines and biologics by, in, and for Africa.

ACHIEVE Africa: Accelerating Health Innovation, Equity, and Development of Vaccines and Biologics in Africa

ACHIEVE Africa extends an open invitation to partners in Africa and worldwide—governments, scientists, institutions, manufacturers, and global partners—to join in building Africa's end-to-end research and development ecosystem, delivering innovation developed in Africa, for Africa.

ACHIEVE Africa already involves scientists from 20 African countries and 50 institutions.

Governments, organizations, and philanthropies are welcome to contribute to scientificstrengthening, technology transfer, human resource development, matched funding, and collaboration.

ACHIEVE Africa was launched through a co-convening by:

Governments, organizations, and philanthropies are welcome to contribute to scientific
strengthening, technology transfer, human resource development, matched funding, and collaboration.